This content is machine translated Neuroendocrine tumors Precision medicine in diagnostics and therapy Thanks to modern imaging and molecular characterization, neuroendocrine tumours can now be detected and classified in a much more targeted manner. New therapeutic procedures such as radioligand therapy and targeted...…
View Post 4 min This content is machine translated GLP1 receptor agonists Positive influence on substance use and addiction GLP1 receptor agonists are gaining increasing recognition, not only for their metabolic benefits in type 2 diabetes, but also for potential effects beyond glycemic control. New experimental evidence suggests that...…
View Post 11 min This content is machine translated Sleep apnea and cardiovascular diseases Breathless through the night 936 million people affected worldwide, a cardiovascular risk profile that complements traditional risk factors and new pharmacological treatment options: Current evidence from 2024-2026 paints a clearer picture of a link...…
View Post 15 min This content is machine translated Diagnostics, differentiation and multimodal therapy Vulvar diseases and vulvodynia Vulvar pain, itching and burning are common complaints – and often misunderstood. An estimated 10 to 28 percent of all women suffer from vulvodynia in the course of their lives;...…
View Post 3 min This content is machine translated From symptom to diagnosis Abdominal pain – Prostate lipoma Lipomas are benign masses that develop from mature adipocytes. In most cases, they are localized subcutaneously. In the soft tissues, the shoulder girdle and back are preferred, but they can...…
View Post 6 min This content is machine translated Acute pulmonary embolism: new AHA/ACC guideline Practical recommendations for risk-stratified triage In February 2026, the American Heart Association (AHA) and the American College of Cardiology (ACC) published a new guideline on the assessment and treatment of acute pulmonary embolism in cooperation...…
View Post 13 min This content is machine translated Why lipoprotein(a) is the biggest therapeutic vacuum in cardiology Lp(a): The underestimated risk factor before the turning point One in five people worldwide has a genetically elevated lipoprotein(a) – and knows nothing about it. Unlike LDL cholesterol, this independent, causally significant risk factor cannot be significantly influenced by...…
View Post 11 min This content is machine translated Modern system therapeutics for hidradenitis suppurativa Immunological dysregulation in the sights of several biologics and “small molecules” The approval of anti-TNF and anti-IL-17 antibody therapies for moderate to severe courses of hidradenitis suppurativa has significantly improved the drug treatment options for this debilitating and potentially mutilating disease...…
View Post 15 min This content is machine translated Perimenopausal depression, PMDS and tokophobia Psychosomatics and mental health in gynecology Mental illnesses in women are common, serious – and systematically underdiagnosed in gynecological practice. The tripled risk of depression in the perimenopause, PMDS (premenstrual dysphoric disorder), which is recognized as...…
View Post 9 min This content is machine translated Polycystic ovary syndrome 2025/2026 New pathophysiology, updated diagnostics and the age of incretin mimetics With a prevalence of 8-13%, polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age – and yet up to 70% of those affected remain...…
View Post 14 min This content is machine translated Heart failure and type 2 diabetes Oral semaglutide and cardiac decompensation in type 2 diabetes The secondary analysis of the SOUL trial from JAMA Internal Medicine 2026 proves for the first time: Oral semaglutide significantly reduces heart failure events in patients with pre-existing HFpEF –...…
